ATE403641T1 - Verfahren zur herstellung von o- desmethylvenlafaxin - Google Patents

Verfahren zur herstellung von o- desmethylvenlafaxin

Info

Publication number
ATE403641T1
ATE403641T1 AT02804479T AT02804479T ATE403641T1 AT E403641 T1 ATE403641 T1 AT E403641T1 AT 02804479 T AT02804479 T AT 02804479T AT 02804479 T AT02804479 T AT 02804479T AT E403641 T1 ATE403641 T1 AT E403641T1
Authority
AT
Austria
Prior art keywords
desmethylvenlafaxin
producing
Prior art date
Application number
AT02804479T
Other languages
English (en)
Inventor
Beat Weber
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23309595&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE403641(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of ATE403641T1 publication Critical patent/ATE403641T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/08—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/10—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT02804479T 2001-12-04 2002-12-03 Verfahren zur herstellung von o- desmethylvenlafaxin ATE403641T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33495301P 2001-12-04 2001-12-04

Publications (1)

Publication Number Publication Date
ATE403641T1 true ATE403641T1 (de) 2008-08-15

Family

ID=23309595

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02804479T ATE403641T1 (de) 2001-12-04 2002-12-03 Verfahren zur herstellung von o- desmethylvenlafaxin

Country Status (28)

Country Link
US (4) US6689912B2 (de)
EP (1) EP1451143B9 (de)
JP (1) JP4342312B2 (de)
KR (1) KR100939650B1 (de)
CN (1) CN1319934C (de)
AR (1) AR037622A1 (de)
AT (1) ATE403641T1 (de)
AU (1) AU2002357049B2 (de)
BR (1) BR0214701A (de)
CA (1) CA2466779C (de)
CO (1) CO5580816A2 (de)
DE (1) DE60228118D1 (de)
DK (1) DK1451143T3 (de)
EC (1) ECSP045135A (de)
ES (1) ES2311647T4 (de)
HU (1) HUP0402269A3 (de)
IL (3) IL162253A0 (de)
MX (1) MXPA04005309A (de)
NO (1) NO20042680L (de)
NZ (1) NZ533316A (de)
PL (1) PL369299A1 (de)
PT (1) PT1451143E (de)
RU (1) RU2317286C2 (de)
SI (1) SI1451143T1 (de)
TW (1) TWI260982B (de)
UA (1) UA80543C2 (de)
WO (1) WO2003048104A1 (de)
ZA (1) ZA200405250B (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6342533B1 (en) 1998-12-01 2002-01-29 Sepracor, Inc. Derivatives of (−)-venlafaxine and methods of preparing and using the same
PL350924A1 (en) * 1999-04-06 2003-02-10 Sepracor Inc Derivatives of venlafaxine and methods of preparing and using the same
DE60221642T3 (de) * 2001-02-12 2017-10-26 Wyeth LLC (n.d.Ges.d. Staates Delaware) O-desmethyl-venlafaxine succinat salz
UA80543C2 (en) * 2001-12-04 2007-10-10 Wyeth Corp Method for the preparation of o-desmethylvenlafaxine
JP2009500420A (ja) * 2005-07-06 2009-01-08 セプラコア インコーポレーテッド エスゾピクロン及びｏ−デスメチルベンラファキシンの組み合わせ、並びに閉経期並びに気分、不安、及び認知障害の治療方法
WO2007067501A1 (en) * 2005-12-05 2007-06-14 Wyeth Process for selective synthesis of enantiomers of substituted 1-(2-amino-1-phenyl-ethyl)-cyclohexanols
EP1973866A1 (de) 2005-12-20 2008-10-01 Synthon B.V. Verfahren zur herstellung von desvenlafaxin
JP2008546718A (ja) * 2006-04-17 2008-12-25 テバ ファーマシューティカル インダストリーズ リミティド 実質的に純粋なｏ−デスメチルベンラファキシン及びその調製方法。
MX2007016179A (es) 2006-04-17 2008-03-11 Teva Pharma Formas cristalinas de o-desmetilvenlafaxina.
WO2008035369A2 (en) * 2006-06-30 2008-03-27 Alembic Limited Novel form of o-desmethyl venlafaxine
WO2008013993A2 (en) * 2006-07-26 2008-01-31 Teva Pharmaceutical Industries Ltd. Processes for the synthesis of o-desmethylvenlafaxine
CA2656167A1 (en) 2006-07-26 2008-01-31 Teva Pharmaceutical Industries Ltd. Processes for the synthesis of o-desmethylvenlafaxine
US20090137846A1 (en) * 2006-07-26 2009-05-28 Valerie Niddam-Hildesheim Processes for the synthesis of O-Desmethylvenlafaxine
EP1934167A2 (de) * 2006-07-26 2008-06-25 Teva Pharmaceutical Industries Ltd. Verfahren zur synthese von o-desmethylvenlafaxin
CA2656285A1 (en) * 2006-07-26 2008-01-31 Teva Pharmaceutical Industries Ltd. Processes for the synthesis of o-desmethylvenlafaxine
US20090069601A1 (en) * 2006-07-26 2009-03-12 Valerie Niddam-Hildesheim Processes for the synthesis of O-desmethylvenlafaxine
US20080221356A1 (en) * 2006-07-26 2008-09-11 Valerie Niddam-Hildesheim Processes for the synthesis of O-desmethylvenlafaxine
WO2008015584A2 (en) * 2006-08-04 2008-02-07 Medichem, S.A. Improved process for synthesizing desvenlafaxine free base and salts or solvates thereof
AU2008211711A1 (en) * 2007-01-31 2008-08-07 Generics [Uk] Limited Process for the preparation of O-desmethyl venlafaxine
EP2049465A2 (de) * 2007-03-14 2009-04-22 Teva Pharmaceutical Industries Ltd. Verfahren zur herstellung von o-desmethylvenlafaxin in festem zustand
CA2692738A1 (en) * 2007-07-12 2009-01-15 Dr. Reddy's Laboratories, Ltd. O-desmethylvenlafaxine
US8329952B2 (en) * 2007-07-16 2012-12-11 Matrix Laboratories Limited Process for the preparation of O-desmethylvenlafaxine succinate polymorphic forms
WO2009034434A2 (en) * 2007-09-10 2009-03-19 Cadila Pharmaceuticals Limited An improved process for the preparation of o-desmethylvenlafaxine
CA2703647A1 (en) 2007-10-26 2009-04-30 Generics [Uk] Limited Process for preparing o-desmethylvenlafaxine
KR101343027B1 (ko) * 2007-11-26 2013-12-18 테바 파마슈티컬 인더스트리즈 리미티드 Ｏ-데스메틸벤라팍신 푸마레이트의 결정형
WO2009084038A2 (en) * 2007-12-28 2009-07-09 Ind-Swift Laboratories Limited Improved process for the preparation of 0-desmethyl-venlafaxine
US20090234020A1 (en) * 2008-03-06 2009-09-17 Valarie Niddam-Hildesheim Processes for the preparation of odesmethylvenlafaxine, free from its dimer impurities
EP2119696A1 (de) 2008-05-16 2009-11-18 Krka Zubereitung von O-Desmethylvenlafaxin-Salzen
EP2119695A1 (de) 2008-05-16 2009-11-18 Krka Zubereitung von O-Desmethylvenlafaxin-Salzen
KR20100132069A (ko) * 2008-06-16 2010-12-16 테바 파마슈티컬 인더스트리즈 리미티드 Ｏ-데스메틸벤라팍신염의 고체 상태
US20100016638A1 (en) * 2008-07-21 2010-01-21 Zdenko Hamersak Method for preparation of o-desmethylvenlafaxine using polythiolates
CN102164886A (zh) * 2008-07-30 2011-08-24 基因里克斯(英国)有限公司 用于制备o-去甲文拉法辛的方法
CZ2008756A3 (cs) 2008-11-27 2010-03-24 Zentiva, A. S. Zpusob prípravy desvenlafaxinu a jeho solí
CZ200969A3 (cs) 2009-02-06 2010-06-30 Zentiva, K.S. Nové soli desvenlafaxinu a zpusob jejich prípravy
CZ2009454A3 (cs) 2009-07-15 2010-11-10 Zentiva, K. S. Zpusob prípravy desvenlafaxinu a jeho solí
JP2012532923A (ja) 2009-07-16 2012-12-20 シプラ・リミテッド Ｏ−デスメチルベンラファキシンの製造方法及びそれに使用される中間体
US20110098506A1 (en) * 2009-10-26 2011-04-28 Intas Pharmaceuticals Limited Method of preparing o-desmethylvenlafaxine
US20110184067A1 (en) * 2010-01-25 2011-07-28 Intas Pharmaceuticals Ltd. O-desmethylvenlafaxine succinate polymorph & process for preparing thereof
WO2011121452A2 (en) 2010-03-29 2011-10-06 Pliva Hrvatska D.O.O. Crystal forms of o-desmethylvenlafaxine fumarate
CZ303249B6 (cs) 2010-04-06 2012-06-20 Zentiva, K.S. Zpusob výroby 4-(2-(substituovaných)-1-(1-hydroxycyklohexyl)ethyl)fenolu O-demethylací jejich methyletheru pomocí nepáchnoucích aromatických thiolu
EP2394976A1 (de) 2010-06-11 2011-12-14 LEK Pharmaceuticals d.d. Verfahren zur Demethylierung aromatischer Methylether unter Verwendung von 3-Mercaptopropionsäure
EP3580198B1 (de) 2017-02-09 2023-08-09 R L Finechem Private Limited Verfahren zur herstellung of1-[2-(dimethylamino)-1-(4-hydroxyphenyl) ethyl]-cyclohexanol und salzen davon
CN109232189B (zh) * 2018-09-25 2021-10-08 杭州盛弗泰新材料科技有限公司 一种高纯度1-羟基芘的制备方法
CN109665966A (zh) * 2018-11-01 2019-04-23 山东蒲济医药科技有限公司 一种琥珀酸去甲文拉法辛化合物的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2741009A1 (de) * 1976-09-22 1978-03-23 Sandoz Ag 4-styryl-4-indolinol-derivate, ihre verwendung und herstellung
US4535186A (en) 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
CA1227304A (en) 1984-08-01 1987-09-29 Raymond C. Francis Delignification of pulp
GB8902209D0 (en) 1989-02-01 1989-03-22 Wyeth John And Brother Limited Preparation of cyclohexanol derivatives and novel thioamide intermediates
US6342533B1 (en) * 1998-12-01 2002-01-29 Sepracor, Inc. Derivatives of (−)-venlafaxine and methods of preparing and using the same
US6197828B1 (en) * 1998-12-01 2001-03-06 Sepracor, Inc. Derivatives of (+)-venlafaxine and methods of preparing and using the same
PL350924A1 (en) 1999-04-06 2003-02-10 Sepracor Inc Derivatives of venlafaxine and methods of preparing and using the same
AU5738700A (en) 1999-06-15 2001-01-02 American Home Products Corporation Enantiomers of o-desmethyl venlafaxine
US20030171324A1 (en) 2000-07-18 2003-09-11 Shyam Ramakrishnan Regulation of human desc1-like serine protease
DE60221642T3 (de) * 2001-02-12 2017-10-26 Wyeth LLC (n.d.Ges.d. Staates Delaware) O-desmethyl-venlafaxine succinat salz
UA80543C2 (en) * 2001-12-04 2007-10-10 Wyeth Corp Method for the preparation of o-desmethylvenlafaxine

Also Published As

Publication number Publication date
BR0214701A (pt) 2004-08-31
CN1319934C (zh) 2007-06-06
DK1451143T3 (da) 2008-11-10
US20040158101A1 (en) 2004-08-12
CA2466779C (en) 2013-11-19
DE60228118D1 (de) 2008-09-18
NZ533316A (en) 2005-12-23
IL162253A0 (en) 2005-11-20
CA2466779A1 (en) 2003-06-12
CN1625546A (zh) 2005-06-08
HK1065778A1 (en) 2005-03-04
PL369299A1 (en) 2005-04-18
TW200301102A (en) 2003-07-01
US20030105358A1 (en) 2003-06-05
TWI260982B (en) 2006-09-01
AU2002357049A1 (en) 2003-06-17
SI1451143T1 (sl) 2008-12-31
EP1451143A1 (de) 2004-09-01
UA80543C2 (en) 2007-10-10
US20090018365A1 (en) 2009-01-15
MXPA04005309A (es) 2004-09-13
ES2311647T4 (es) 2009-11-10
RU2317286C2 (ru) 2008-02-20
EP1451143B9 (de) 2009-08-12
US7435854B2 (en) 2008-10-14
PT1451143E (pt) 2008-10-21
ECSP045135A (es) 2004-07-23
ES2311647T3 (es) 2009-02-16
NO20042680L (no) 2004-06-25
KR20050044671A (ko) 2005-05-12
JP4342312B2 (ja) 2009-10-14
US6689912B2 (en) 2004-02-10
JP2005511681A (ja) 2005-04-28
AU2002357049B2 (en) 2009-07-16
KR100939650B1 (ko) 2010-02-05
HUP0402269A2 (hu) 2005-02-28
IL194034A (en) 2010-12-30
ZA200405250B (en) 2005-12-28
US20070225525A1 (en) 2007-09-27
WO2003048104A1 (en) 2003-06-12
RU2004120284A (ru) 2005-04-10
IL162253A (en) 2009-02-11
CO5580816A2 (es) 2005-11-30
AR037622A1 (es) 2004-11-17
EP1451143B1 (de) 2008-08-06
HUP0402269A3 (en) 2010-06-28

Similar Documents

Publication Publication Date Title
DE60221399D1 (de) Verfahren zur herstellung von mitteldistillaten
ATE403641T1 (de) Verfahren zur herstellung von o- desmethylvenlafaxin
ATE468309T1 (de) Verfahren zur herstellung von olefinen
ATE364497T1 (de) Verfahren zur herstellung von verbindungsprofilen
DE60230908D1 (de) Verfahren zur herstellung von polyarylenethern
AT7110U9 (de) Verfahren zur herstellung von amlodipinmaleat
ATE453648T1 (de) Verfahren zur herstellung von hexahydrofuroc2,3- büfuran-3-ol
ATE286011T1 (de) Verfahren zur herstellung von 1-octen
ATE374463T1 (de) Verfahren zur herstellung von oxazolidinonen
ATE315099T1 (de) Verfahren zur herstellung von tagatose
DE60126336D1 (de) Verfahren zur herstellung von hochreinen durchscheinenden perfluorelastomer-gegenständen
DE60200836D1 (de) Verfahren zur herstellung von kunststoffteilanordnungen
ATE296287T1 (de) Verfahren zur herstellung von repaglinide
ATE506351T1 (de) Verfahren zur herstellung von 10,11-dihydro-10- oxo-5h-dibenzoäb,füazepin-5-carboxamid
DE50102444D1 (de) Verfahren zur herstellung von isocyanatoorganosilanen
ATE316518T1 (de) Verfahren zur herstellung von (r)-2-alkyl-3- phenyl-1-propanolen
DE60236754D1 (de) Verfahren zur herstellung von polyoxyalkylenpolyetherprodukten
ATE553103T1 (de) Verfahren zur herstellung von (s)-pantoprazol
DE60210911D1 (de) Verfahren zur Herstellung von dehnungserfassenden Vorrichtungen
ATE441662T1 (de) Verfahren zur herstellung von echinocandinderivaten
DE50111560D1 (de) Verfahren zur herstellung von guerbetalkoholen
DE60103173D1 (de) Verfahren zur herstellung von 3-amino-2-chlor-4-methylpyridin
ATE360610T1 (de) Verfahren zur herstellung von cilastatin
ATE273315T1 (de) Verfahren zur herstellung von n- phosphonomethyliminodiessigsäure
DE50303611D1 (de) Verfahren zur herstellung von polyisobuten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1451143

Country of ref document: EP

REN Ceased due to non-payment of the annual fee